Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Right now, patients with obesity and cirrhosis ...

Familial hypobetalipoproteinemia (FHBL), caused by apolipoprotein B (APOB) variants, disrupts APOB-containing lipoprotein ...

Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of ...

Newly discovered mechanism by which oral bacteria affect gut health coincides with worsening liver health in patients with ...

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

New data links the liver receptor GPR110 to sex-specific progression of metabolic dysfunction-associated steatohepatitis.

The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

Lucknow: Hepatic venous pressure gradient (HVPG), special medical test to gauge pressure inside liver, was performed for the ...

The FDA expanded the indication for semaglutide (Wegovy) to treating adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), the agency announced. The glucagon-like peptide-1 ...

Fatty liver disease has become one of the most common silent diseases in our country, but this daily drink can help improve ...

Fatty liver disease is not restricted to adults, and its incidence in children and adolescents is continuously increasing.

New analysis shows alcohol-related liver disease remains a major cause of cirrhosis and liver death. Read more.